Document ID: chunk:federal_register_of_legislation:C2015C00461:section:10:p24
Version: federal_register_of_legislation:C2015C00461
Segment Type: section
Provision Reference: s 10 (pt 24/24)
Character Range: 74919–76883

not
                                                     commenced or to be commenced

Endnote 3—Legislation history

Act                                                                                     Number and year  Assent       Commencement                                                      Application, saving and transitional provisions
Psychotropic Substances Act 1976                                                        87, 1976         25 Aug 1976  s 9: 1 Nov 1984 (s 2(2) and gaz 1984, No S426)
                                                                                                                      Remainder: 25 Aug 1976 (s 2(1))
Customs Administration (Transitional Provisions and Consequential Amendments) Act 1985  39, 1985         29 May 1985  s 4 and Sch: 10 June 1985 (s 2)                                   s 4
Customs Administration (Transitional Provisions and Consequential Amendments) Act 1986  10, 1986         13 May 1986  s 2(2), 4 and Sch: 13 May 1986 (s 2(1))                           s 2(2) and 4
Customs, Excise and Bounty Legislation Amendment Act 1995                               85, 1995         1 July 1995  s 18 and Sch 9 (item 85): 1 July 1995 (s 2(1))                    s 18
Customs and Other Legislation Amendment (Australian Border Force) Act 2015              41, 2015         20 May 2015  Sch 6 (items 182–185) and Sch 9: 1 July 2015 (s 2(1) items 2, 7)  Sch 6 (item 185) and Sch 9

Endnote 4—Amendment history

Provision affected        How affected
s 2A....................  ad No 39, 1985
                          am No 85, 1995; No 41, 2015
s 3.....................  am No 41, 2015
s 9.....................  am No 10, 1986; No 85, 1995; No 41, 2015

 The names printed in capitals in the left‑hand column are the International Non‑Proprietary Names (INN). With one exception ( (+)‑LYSERGIDE), other non‑proprietary or trivial names are given only where no INN has yet been proposed.